NYSE: OGNOrganon & Co Stock Ownership - Who owns Organon & Co?
Insider buying vs selling
Have Organon & Co insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ferreira Juan Camilo Arjona | Head of RD CMO | 2025-08-11 | 4,122 | $9.22 | $38.00kSell |
| Carrie Smith Cox | Director | 2025-05-14 | 12,469 | $8.07 | $100.59kBuy |
| Aaron Falcione | Chief Human Resources Officer | 2025-05-07 | 5,500 | $8.77 | $48.24kBuy |
| Daniel Karp | Executive VP Corp. Dev. | 2025-05-06 | 3,500 | $8.24 | $28.83kBuy |
| Kirke Weaver | Gen. Counsel Corp. Secy. | 2025-05-06 | 8,045 | $9.21 | $74.05kBuy |
| Matthew M. Walsh | Chief Financial Officer | 2025-05-05 | 11,400 | $8.82 | $100.55kBuy |
| Kevin Ali | Chief Executive Officer | 2025-05-05 | 34,000 | $8.81 | $299.37kBuy |
| Kathryn Dimarco | Corporate Controller | 2025-03-31 | 1,471 | $14.51 | $21.34kSell |
| Matthew M. Walsh | Chief Financial Officer | 2025-03-31 | 3,819 | $14.51 | $55.41kSell |
| Kevin Ali | Chief Executive Officer | 2025-03-31 | 26,964 | $14.51 | $391.25kSell |
OGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OGN insiders and whales buy or sell their stock.
OGN Shareholders
What type of owners hold Organon & Co stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 12.42% | 32,277,543 | $335.69M | Institution |
| Blackrock Inc | 11.98% | 31,142,122 | $323.88M | Institution |
| Massachusetts Financial Services Co | 3.94% | 10,237,203 | $106.47M | Institution |
| State Street Corp | 3.66% | 9,520,594 | $99.01M | Institution |
| Millennium Management LLC | 3.50% | 9,090,467 | $94.54M | Institution |
| Lsv Asset Management | 3.07% | 7,989,460 | $83.09M | Institution |
| Ubs Group Ag | 2.29% | 5,959,792 | $61.98M | Institution |
| Morgan Stanley | 2.21% | 5,746,226 | $59.76M | Institution |
| Citadel Advisors LLC | 2.10% | 5,462,410 | $56.81M | Institution |
| Nordea Investment Management Ab | 1.89% | 4,904,076 | $51.00M | Institution |
OGN vs General Drug Manufacturer Stocks
Organon & Co Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.